Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
New AI Tool Makes Speedy Gene Editing Possible
An artificial intelligence (AI) program may enable the first simple production of customizable proteins called […]
Computer Tool Can Track Stroke Rehabilitation to Boost Recovery
A sensor-equipped computer program can accurately identify and count arm movements in people undergoing stroke […]
Next-Generation Immunotherapy Drug Shows Continued Promise in Several Advanced-Stage Cancers
Initial study results show that an experimental drug, called nemvaleukin alfa, when used alone or […]
New Research Finds Computer Assisted Colonoscopy Identify More Precancerous Polyps Compared to Traditional Colonoscopy
Colonoscopies performed with computer-aided detection, or artificial intelligence, (AI) saw an increase in the overall […]
Structure of a Bacterial "Drug Pump" Reveals New Way to Counter Hospital-borne Infection
By revealing the structure of a protein used by bacteria to pump out antibiotics, a […]
Researchers Discover New Model for "Global" DNA Repair
Two studies provide a radically new picture of how bacterial cells continually repair damaged sections […]
Artificial Intelligence Tool Improves Accuracy of Breast Cancer Imaging
A computer program trained to see patterns among thousands of breast ultrasound images can aid […]
New Class of Compounds Found to Block Coronavirus Reproduction
A human genetic mechanism hijacked by SARS-CoV-2, the coronavirus behind the COVID-19 pandemic, to help […]
Implantable Brain Device Relieves Pain in Early Study
A computerized brain implant effectively relieves short-term and chronic pain in rodents, a new study […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more